CARSCADDEN GWEN R. 4
4 · Intersect ENT, Inc. · Filed Jan 19, 2018
Insider Transaction Report
Form 4
CARSCADDEN GWEN R.
Chief People Officer
Transactions
- Award
Stock Options (Right to buy)
2018-01-17+24,500→ 24,500 totalExercise: $33.95Exp: 2028-01-16→ Common Stock (24,500 underlying) - Award
Common Stock
2018-01-17+5,300→ 9,156 total
Footnotes (2)
- [F1]Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in equal annual installments over three years commencing on January 1, 2018.
- [F2]1/8th of the shares subject to the option vest on July 1, 2018 and 1/48th of the total shares subject to the option vest monthly thereafter over 42 months.